Sage Therapeutics (SAGE) PT Raised to $7 at RBC Capital
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on Sage Therapeutics (NASDAQ: SAGE) to $7.00 (from $6.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Lululemon (LULU) PT Lowered to $115 at Freedom Broker
- Hello Group (MOMO) PT Lowered to $8 at StoneX, Buy Rating Maintained
- CIENA (CIEN) PT Lowered to $394 at UBS on Group Multiple Compression
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
